U.S. Office REITs Stock News

NasdaqGS:MBX
NasdaqGS:MBXPharmaceuticals

MBX Biosciences Advances Obesity And PBH Pipeline As Shares Surge

MBX Biosciences (NasdaqGS:MBX) reported encouraging preliminary Phase 1 data for its lead obesity candidate, MBX 4291, with early weight loss signals and potential for once-monthly dosing. The company introduced a new preclinical obesity program, MBX 5765, expanding its early stage pipeline. MBX also shared positive proof-of-concept results from its Imapextide Phase 2a trial in post-bariatric hypoglycemia. These updates arrive with MBX Biosciences trading at $37.5, after a very large 1-year...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

Kyivstar Starlink Tie Up Puts Focus On Resilience And Valuation Potential

Kyivstar Group (NasdaqGS:KYIV) has expanded its collaboration with Starlink, becoming the exclusive provider of fully integrated, multi layer connectivity solutions for Ukrainian businesses and public sector institutions. The arrangement focuses on combining terrestrial and satellite high speed internet to improve coverage, particularly in regions with limited connectivity. The move is positioned as a way to support national infrastructure resilience and broaden Kyivstar Group's role in...